Although recent technological advances (such as continuous glucose monitoring systems and insulin pumps) have significantly improved metabolic control and quality of life, optimal metabolic control in T1D has not yet been achieved globally or in Türkiye [3]. The gene discussed is INS; the disease is type 1 diabetes mellitus.